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he small guanosine triphosphate (GTP)–binding
protein ADP-ribosylation factor (ARF) 6 regulates
membrane recycling to regions of plasma membrane
remodeling via the endocytic pathway. Here, we show that
GTP–bound ARF6 interacts with Sec10, a subunit of the
exocyst complex involved in docking of vesicles with the
plasma membrane. We found that Sec10 localization in
the perinuclear region is not restricted to the 
 
trans
 
-Golgi
network, but extends to recycling endosomes. In addition,
we report that depletion of Sec5 exocyst subunit or dominant
T
 
inhibition of Sec10 affects the function and the morphology
of the recycling pathway. Sec10 is found to redistribute to
rufﬂing areas of the plasma membrane in cells expressing
GTP-ARF6, whereas dominant inhibition of Sec10 interferes
with ARF6-induced cell spreading. Our paper suggests
that ARF6 speciﬁes delivery and insertion of recycling
membranes to regions of dynamic reorganization of the
plasma membrane through interaction with the vesicle-
tethering exocyst complex.
 
Introduction
 
To form membrane extensions such as lamellipodia at the
leading edge of migrating cells, local polymerization of actin
filaments must be coordinated with polarized insertion of
membrane components. It has long been proposed that mem-
branes inserted at the leading edge would be derived from
the recycling of surface components, internalized via the endo-
cytic pathway (Bretscher, 1996). Transferrin receptors (TfRs),
which are internalized via clathrin-coated pits and delivered to
tubulo-vesicular recycling endosomes (REs), have been shown
to recycle back from REs and accumulate at the leading edge of
migrating fibroblasts (Hopkins et al., 1994). More recently,
polarized recycling to the leading edge has been reported for
integrin receptors, and for the v-SNARE protein VAMP3, a
marker for REs (Daro et al., 1996), during phagocytosis in
macrophages (Bajno et al., 2000; Pierini et al., 2000; Laukaitis
et al., 2001; Roberts et al., 2001; Niedergang et al., 2003). All
together these observations indicate that the RE may serve as a
storage compartment regulating the availability of plasma
membrane lipid and protein components needed for cells un-
dergoing changes in morphology (Lecuit and Pilot, 2003).
However, little is yet known about how post-endocytic recy-
cling is polarized in order to contribute to local membrane de-
livery at specialized plasma membrane locations.
ADP-ribosylation factor (ARF) 6, a member of the family
of ARF small GTP-binding proteins, regulates membrane
movement between the plasma membrane and early endocytic
compartments (Chavrier and Goud, 1999). Like all small
GTP-binding proteins, ARF6 cycles between active GTP
and inactive GDP-bound forms, and studies from several
laboratories have indicated that ARF6 activation occurs at
the plasma membrane (D’Souza-Schorey et al., 1998; Frank
et al., 1998; Franco et al., 1999; Vitale et al., 2002). The ARF6
GDP/GTP cycle has been shown to regulate the uptake
and recycling of plasma membrane proteins to generate
membrane protrusive structures concomitant with alterations
in the cortical actin cytoskeleton (Radhakrishna and Don-
aldson, 1997; D’Souza-Schorey et al., 1998; Franco et
al., 1999; Palacios et al., 2001). This specific and essential
role of ARF6 is further reflected by its involvement in vari-
ous cellular processes requiring transient cellular polarization
such as cell spreading, cell motility and phagocytosis (Song
et al., 1998; Zhang et al., 1998; Radhakrishna et al., 1999;
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Palacios et al., 2001; Santy and Casanova, 2001; Niedergang
et al., 2003). ARF6 activity is also required for regulated se-
cretion in adipocytes and neuroendocrine cells (Yang and
Mueckler, 1999; Vitale et al., 2002). These observations
point to a crucial role for ARF6 in plasma membrane and
cortical actin remodeling through the regulation of mem-
brane recycling to specialized regions of the plasma mem-
brane. However, our understanding of the mechanism of
ARF6 membrane remodeling is still limited and awaits the
identification of new effector pathways.
The delivery of membrane vesicles to spatially restricted
areas of the plasma membrane is a multi-step process requir-
ing polarized transport, restricted docking and fusion of ves-
icles to specific plasma membrane sites (for review see Finger
and Novick, 1998). Recently, an eight-subunit complex
termed the exocyst complex has been shown to mediate the
vectorial targeting of secretory vesicles to sites of membrane
insertion in yeast (TerBush and Novick, 1995). The exocyst
complex is conserved in mammals where it plays a role in
vesicle delivery from a post-Golgi compartment to specific
plasma membrane domains of epithelial and neuronal cells
(Grindstaff et al., 1998; Hazuka et al., 1999; Lipschutz et
al., 2000; Vega and Hsu, 2001; Yeaman et al., 2001). Al-
though little is known about the regulation of exocyst com-
plex function, interactions between small GTP binding pro-
teins and exocyst complex subunits have been reported (for
review see Lipschutz and Mostov, 2002). These interactions
suggest a potential connection between signaling and modu-
lation of polarized membrane growth by the exocyst com-
plex. In this study, we identify the exocyst complex as a
novel effector for ARF6, mediating endocytic membrane re-
cycling to dynamic regions of the plasma membrane.
 
Results
 
Sec10 interacts with GTP-ARF6
 
We used a yeast two-hybrid screen in order to identify new
ARF6 GTP-binding effector proteins. 2,000,000 clones of a
human placenta cDNA library were screened with the con-
stitutively activated ARF6 mutant ARF6-Q67L as a bait. 43
clones were isolated that associated specifically with ARF6-
Q67L compared with negative controls (vector, nucleotide-
binding–defective ARF6-T27N, and lamin). Among these,
two clones corresponded to the carboxy-terminal region of
the human Sec10 subunit (aa 378–708) of the exocyst com-
plex (Guo et al., 1997, 1999a). Fig. 1 A documents the two-
hybrid interaction of Sec10/378–708 (hereafter called
Sec10CTer) with the activated mutant form ARF6-Q67L;
no such interaction was detected with wild-type and nucle-
otide-binding–defective ARF6-T27N. In addition, there
was also no interaction of Sec10CTer with the activated
form of Rac1, RhoG, RhoB, Cdc42, or Rab6 (unpublished
data). Further deletion of the amino- or carboxy-terminal
end of Sec10CTer (Sec10/489–708 and Sec10/378–605, re-
spectively) prevented two-hybrid association with ARF6-
Q67L (unpublished data). Introduction of two mutations in
the ARF6 effector region known to interfere with function
(ARF6-Q37E/S38I/Q67L; Al-Awar et al., 2000) abolished
the interaction with Sec10CTer, as did deletion of the 13
most amino-terminal residues of ARF6 (unpublished data).
All together, these observations are indicative of effector-
domain and amino-terminal helix-dependent interactions of
GTP-ARF6 with Sec10. Our attempts to coimmunopre-
cipitate endogenous or overexpressed Sec10 with activated
ARF6 failed, suggesting that the ARF6–Sec10 complex is
transient or unstable in the conditions used for immunopre-
cipitation. However, we could observe ARF6–Sec10 interac-
tion using recombinant GST-tagged Sec10 in two different
ways. First, by incubating GST-Sec10 with lysates of cells
overexpressing ARF1 and ARF6 variants. The GST pull-
down assay showed a specific association of HA-tagged
Figure 1. Interaction of GTP-ARF6 with Sec10. (A) The indicated 
ARF6 variants as fusions to the LexA DNA-binding domain were 
expressed in the L40 yeast two-hybrid reporter strain together with the 
carboxy-terminal region of human Sec10 (Sec10CTer; aa 378–708 
expressed as a fusion to the Gal4 transcriptional activation domain). 
Growth on medium lacking histidine indicates a positive two-hybrid 
interaction. (B) To assess the interaction of ARF6 with Sec10, HeLa 
cells were transfected with carboxy-terminally HA-tagged ARF6 or 
ARF1 variants, and cell extracts were incubated with Sec10 expressed 
and purified from Escherichia coli as a fusion to GST, or with GST 
as a control. Complexes were immobilized on glutathione-Sepha-
rose, extensively washed, and separated by SDS-PAGE together 
with aliquots of total lysates. Detection of bound protein was per-
formed by immunoblotting with anti-HA–tagged mAb. ARF1T, 
ARF1-T31N; ARF1Q, ARF1-Q71L; ARF6T, ARF6-T27N; ARF6Q, 
ARF6-Q67L. (C) Beads loaded with GST or GST-Sec10 were in-
cubated with recombinant ARF6 loaded with GDP or GTP. Beads 
were recovered and bound proteins were eluted. 10% of bound ma-
terial (top) together with 1% of unbound material (bottom) was im-
munoblotted with anti-ARF6. One representative experiment out 
of three is shown. Molecular masses are in kD. 
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ARF6-Q67L, but not ARF6-T27N with Sec10 (Fig. 1 B).
In contrast, both mutant forms of ARF1 showed only a
weak interaction with GST-Sec10. To further confirm the
nucleotide specificity of the ARF6–Sec10 interaction, GST-
Sec10 was incubated with purified recombinant ARF6
loaded either with GTP or GDP as described in the Materi-
als and methods section. The data clearly demonstrated a di-
rect and preferential interaction of GTP-ARF6 with Sec10
as compared with GDP-ARF6 (Fig. 1 C, top). Therefore, we
conclude that the Sec10 subunit of the exocyst complex is
able to interact preferentially with the activated form of the
small GTP-binding protein ARF6.
 
Sec10 localizes to perinuclear secretory and endocytic 
recycling compartments
 
To determine the intracellular distribution of Sec10, we raised
pAbs against an amino-terminal Sec10 peptide. Consistent
with the predicted mol wt of mammalian Sec10 (Guo et al.,
1997), these antibodies detected an 
 
 
 
77-kD single band on
immunoblot of normal rat kidney (NRK) and MDCK cell ex-
tracts (Fig. S1 A, available at http://www.jcb.org/cgi/content/
full/jcb.200305029/DC1) that coimmunoprecipitated with
Sec8 (Fig. S1 B).
These antibodies were used to determine the intracel-
lular distribution of Sec10 and the exocyst complex by
immunofluorescence and immuno-EM. In nonpolarized
MDCK cells and in NRK cells, Sec10 localization was pre-
dominantly perinuclear and partially overlapped with the
distribution of the Golgi marker GM130 (Fig. 2, A–C and
D–F, respectively). Immuno-EM of nonpolarized MDCK
cells and NRK cells revealed localization of endogenous
Sec10 to tubulo-vesicular structures close to Golgi cister-
nae and corresponding presumably to the TGN (Fig. 3, A
and D, respectively; arrows). These observations are in
agreement with reported association of the Sec6, Sec8, and
Exo70 exocyst subunits with the TGN (Vega and Hsu,
2001; Yeaman et al., 2001). Interestingly, Sec10 was also
detected in scattered vesicular structures visible by immu-
nofluorescence microscopy in MDCK (Fig. 2 B, arrows)
and in NRK cells (Fig. 2, E and H; arrows). By immuno-
EM, some of the Sec10-positive structures appeared as pe-
ripheral vesicles closely apposed to endosomal organelles
(Fig. 3, B–D; asterisks) with a characteristic vacuolar re-
gion and few intraluminal vesicles (Fig. 3, B and C,
MDCK cells; Fig. 3 D, NRK cells, arrowheads point to
Sec10 labeling). As shown in Fig. 3 C, these vesicular ele-
ments are likely to correspond to endosomal buds. The lo-
calization of Sec10 to endocytic compartments was studied
by double-labeling immunofluorescence microscopy anal-
ysis of NRK cells with a combination of anti-TfR mAb
and anti-Sec10 antibodies. A significant overlap of Sec10
and TfRs was observed in perinuclear compartments (Fig.
2, G–I; arrowheads). To ascertain the presence of Sec10 in
recycling endocytic compartments, we used whole-mount
immuno-EM as initially described by Stoorvogel et al.
(1996). NRK cells were incubated with HRP-conjugated
transferrin (Tf) to fill the entire recycling pathway,
and were processed for whole-mount immuno-EM as de-
scribed in the Materials and methods section. Anti-Sec10
antibodies decorated vesicular endosomal structures and
appeared enriched in endosomal buds (Fig. 3, E and F; ar-
rows), some of which were also labeled for TfRs (Fig. 3 F,
arrow). Based on these data, we conclude that beside its
previously known localization to the TGN and to some
Figure 2. Immunofluorescence localization of 
Sec10 to the perinuclear region of MDCK and 
NRK cells. The localization of Sec10 (B, E, and H) 
and the Golgi marker GM130 protein (A and D), or 
the RE marker TfR (G), was compared on single 
optical section by confocal immunofluorescence 
microscopy in subconfluent MDCK cells (A–C) and 
in NRK cells (D–I) grown on coverslips. To detect 
Sec10, cells were labeled with pAbs recognizing 
an amino-terminal peptide derived from Sec10 
(aa 6–20). (C, F, and I) Merged images showing 
Sec10 in red and GM130 (C and F) or TfR (I) in 
green depict colocalization in yellow. Sec10 is 
mostly found at the perinuclear region of the cells, 
where its distribution partially overlaps with the 
Golgi marker GM130 (C and F) and the RE marker 
TfR (I). Some Sec10-positive structures are also 
visible at the cell periphery (arrows). Arrowheads 
in H and I depict colocalization of Sec10 and TfR 
in the perinuclear RE. Bars, 10  m. 
1114 The Journal of Cell Biology 
 
|
 
 
 
Volume 163, Number 5, 2003
 
specialized sites at the plasma membrane (Grindstaff et al.,
1998; Hazuka et al., 1999; Lipschutz et al., 2000; Vega
and Hsu, 2001), the exocyst complex is also present in the
recycling endocytic pathway.
 
Interfering with Sec10–exocyst complex function 
affects trafficking in the recycling pathway
 
Deletion of the carboxy-terminal region of yeast or mamma-
lian Sec10 creates a dominant-negative form that inhibits exo-
cyst complex activity (Roth et al., 1998; Vega and Hsu,
2001). Based on these observations, we fused aa 1–537 of
human Sec10 at the carboxy-terminal end of GFP (GFP-
Sec10NTer), and expressed this construct in NRK cells to as-
sess its effect on the recycling pathway. Perinuclear REs la-
beled with TfRs underwent a striking reorganization in NRK
cells expressing GFP-Sec10NTer. TfRs were found in an ex-
tensive network of long and thin tubular extensions of the
perinuclear region (Fig. 4 B, arrows). Tubules were observed
in 
 
 
 
30% of Sec10NTer-expressing cells and never seen in
nontransfected cells (Fig. 4 B, cell at bottom right) or in cells
expressing full-length Sec10 (unpublished data). Fluorescent
Tf internalized for 30 min was also found in these tubular
structures in Sec10NTer-expressing NRK cells (Fig. 4 D, ar-
rows). Expression of GFP-Sec10NTer had no effect on the
morphology of the TGN (Fig. 4 F, labeled with TGN38), the
Golgi apparatus (labeled with GM130; unpublished data), or
early endosomes (stained with EEA1; unpublished data).
These results suggested that the exocyst complex has a spe-
cific function in the recycling pathway. This issue was ad-
dressed by transfecting HeLa cells with a 21-bp double-
stranded small interfering RNA (siRNA) designed from the
sequence encoding the human Sec5 exocyst complex sub-
unit, which knocked down Sec5 to undetectable level after
72 h (Fig. 5 A, left). By phase-contrast microscopy, Sec5-
depleted cells appeared rounder than mock-transfected cells,
but growth of both cell populations was comparable (un-
published data). After 72 h of treatment, cells were allowed
to internalize Alexa
 
®
 
 488–labeled Tf for 30 min, and
FACS
 
®
 
 analysis was used to measure the kinetics of Tf recy-
cling (Fig. 5 B). Depletion of Sec5 levels correlated with a
significant and reproducible diminution of Tf release as
compared with control mock-transfected cells. All together,
these observations are consistent with a role for the exocyst
complex in the recycling pathway.
 
GTP-ARF6 promotes the redistribution of the 
exocyst complex from the perinuclear region 
to the plasma membrane
 
To investigate the role of ARF6 in exocyst complex function
in the recycling pathway, we first examined the effect of HA-
tagged dominant-inhibitory ARF6-T27N on the distribu-
tion of the complex visualized with anti-Sec10 antibodies.
As shown in Fig. 6 (A and B), the distribution of Sec10 in
the perinuclear region was not affected in MDCK cells ex-
Figure 3. Sec10 localizes on tubulo-vesicular extensions of the TGN and recycling 
endosomes. (A–D) Ultrathin cryosections of nonpolarized MDCK cells (A–C) and NRK cells 
(D) labeled with anti-Sec10 pAbs, followed by protein A 10-nm gold. Sec10 is found in 
distinct locations on tubulo-vesicular membrane extensions of the TGN (A and D, arrows) 
and in close proximity of early endosomes (asterisks) on vesicles (B and D, arrowheads) and 
buds (C, arrowheads). (E and F) NRK cells were incubated with HRP-conjugated Tf to load 
the recycling compartments, and were processed for whole-mount immuno-EM. Samples 
were immunolabeled for Sec10 (E, 10-nm gold), or double labeled for Sec10 (10-nm gold) 
and TfR (5-nm gold) (F). Sec10 labeling was observed on HRP-filled endosomes and appeared 
enriched in endosomal buds (E, arrows), some of which were also positive for TfR (F, arrow). 
GA, Golgi apparatus; LE, late endosome; PM, plasma membrane. Bars, 200 nm (A–D), 
75 nm (E), and 60 nm (F). 
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pressing ARF6-T27N, indicating that steady-state associa-
tion of the exocyst complex to perinuclear compartments
does not require GTP-ARF6. Next, the effect of the consti-
tutively activated ARF6-Q67L mutant was investigated. As
reported in D’Souza-Schorey et al. (1998), a significant frac-
tion of ARF6-Q67L was found at the surface of MDCK
cells that exhibited long membrane extensions and ruffles
(Fig. 6, D, F, and H, and see below). As shown in Fig. 6 C
and D, loss of perinuclear Sec10 staining was observed in
ARF6-Q67L-expressing cells. This effect was better visual-
ized in cells expressing medium to high levels of GTP-
ARF6. In contrast, neither the distribution of GM130 nor
that of TGN38 was affected by expression of ARF6-Q67L
even at high levels (Fig. 6; E and F and G and H, respec-
tively). Similar observations were made in HeLa and NRK
cells (unpublished data).
Disappearance of Sec10 from the perinuclear region of
cells overexpressing ARF6-Q67L suggested that the complex
could be displaced from perinuclear compartments to the cell
periphery as a result of a Sec10 interaction with GTP-ARF6
at the plasma membrane. However, immunofluorescence la-
beling did not reveal plasma membrane staining of Sec10 in
ARF6-Q67L–expressing cells (Fig. 6, C and D). It is of note
that a series of anti-Sec6/8 mAbs has been recently character-
ized showing mutually exclusive staining of the TGN or the
plasma membrane (Yeaman et al., 2001), suggesting the ex-
istence of distinct exocyst complex conformations. There-
fore, it is possible that epitope masking may have prevented
Sec10 recognition at the plasma membrane with anti-Sec10
peptide antibodies in the immunofluorescence analyses de-
scribed above. As Sec10 labeling in close proximity to the
plasma membrane was detected by immuno-EM (Fig. 3, and
unpublished data), we assessed the localization of Sec10 in
MDCK Tet-Off™ cells stably expressing HA-tagged ARF6-
Q67L at EM level. Two clones showing no detectable ex-
pression of ARF6-Q67L in the presence of doxycycline, but
an approximate twofold overexpression compared with en-
dogenous ARF6 upon removal of the drug, were selected
and gave similar results (Fig. S2 A, available at http://
www.jcb.org/cgi/content/full/jcb.200305029/DC1; unpub-
lished data). Phase-contrast analysis of the clones grown in
Figure 4. Morphological alterations of recycling endosomes in 
cells expressing Sec10NTer. (A and B) NRK cells were transiently 
transfected with GFP-tagged Sec10NTer. 24 h after transfection, 
cells were fixed and stained with anti-TfR mAb. GFP-Sec10NTer is 
shown in A, TfR is shown in B. Arrows in B depict beaded tubular 
structures containing TfRs. (C and D) After transfection, NRK cells 
were incubated with Alexa
® 546–labeled Tf at 37 C for 20 min. 
The cells were washed, fixed, and observed by confocal microscopy. 
GFP-Sec10NTer is shown in C. Tf is depicted in D. Arrows in D 
depict Tf accumulation in beaded tubular structures that are induced 
by Sec10NTer expression. (E and F) Cells transfected with GFP-
Sec10NTer were stained for TGN38 (F). GFP-Sec10NTer is shown 
in E. Arrows in F indicate normal TGN structures.
Figure 5. Kinetics of Tf recycling in control and Sec5 siRNA-
treated HeLa cells. (A) Equal protein loadings of lysates of either 
mock-transfected cells (two independent experiments) or cells 
transfected with siRNA directed against the exocyst Sec5 subunit 
(three independent experiments) were separated by SDS-PAGE 
and analyzed by immunoblotting with anti-Sec5 antibodies (left), 
or anti-actin antibodies as a control (right). 72 h of treatment with 
siRNA causes depletion in the Sec5 subunit. (B) HeLa cells were 
transfected with Sec5 siRNA or were mock transfected. 72 h after 
transfection, cells were detached and incubated in medium containing 
50 nM Alexa
® 488–Tf for 30 min at 37 C. Recycling of Tf was then 
measured by FACS
® as described in the Materials and methods 
section. The mean Alexa
® 488–Tf fluorescence was calculated for 
each time point measured in duplicate, and expressed as a percentage 
of the fluorescence obtained after 30 min of internalization (zero 
time point). The plots represent the mean   SEM of three independent 
experiments. Cells depleted in the Sec5 subunit recycle Tf with 
reduced kinetics. 
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the absence of doxycycline revealed that expression of GTP-
ARF6 had a strong effect on the morphology of MDCK
cells, forming loose colonies as compared with compact colo-
nies observed when the clones were grown in the presence of
the drug (Fig. S2, compare B with C). Overexpression of
GTP-ARF6 triggered the formation of extensive membrane
ruffles and of thin, long membrane protrusions (several tens
of 
 
 
 
m in length) with fan-shaped ends (Fig. S2 C). At the
EM level, cells expressing GTP-ARF6 exhibited extensive
folds and extensions that appeared as membrane-enclosed
structures with an electrolucent lumen in cross section (Fig.
S2, compare D–F with Fig. 7, asterisks). Immunogold label-
ing revealed that Sec10 accumulated along the plasma mem-
brane folds (Fig. 7, arrows), as well as with plasma membrane
invaginations and tubulo-vesicular structures in close prox-
imity to the ruffled plasma membrane (Fig. 7, arrowheads),
whereas no such accumulations were visible in doxycycline-
treated cells (Fig. S2, D and E). All together, these data suggest
that the exocyst complex, by interacting with GTP-ARF6, is
recruited to the plasma membrane in membrane extensions
that form on activation of ARF6.
 
Inhibition of GTP-ARF6–induced membrane spreading 
by dominant-negative Sec10
 
On the basis of the above findings, we postulated that if
the exocyst complex was required downstream of ARF6
for post-endocytic recycling, coexpression of the inhibi-
tory Sec10 mutant together with GTP-ARF6 should affect
ARF6-induced membrane recycling and inhibit subsequent
plasma membrane extension. Expression of ARF-Q67L in
NRK cells has been shown to induce cell spreading (Song et
al., 1998). Therefore, we expressed ARF6-Q67L alone or in
combination with inhibitory Sec10NTer in NRK cells, and
measured the projected cell area as described in the Materials
and Methods section. Confirming previous findings (Song
et al., 1998), expression of ARF6-Q67L resulted in a statisti-
cally significant increase of cell area when compared with
GFP-expressing control cells (Fig. 8, compare A with B; see
quantification of cell area in D). In contrast, coexpression of
activated ARF6 with dominant-negative Sec10NTer led to a
significant reduction in cell area as a result of the inhibition
of cell spreading (Fig. 8, C and D). Reduction of cell area
was also observable in cells expressing Sec10NTer alone
(Fig. 8 D). The Sec10NTer construct is unlikely to exert its
inhibitory effect by titrating GTP-ARF6, as Sec10NTer re-
tains only the first 159 amino acids of the ARF6-binding
domain, insufficient to support ARF6 binding by yeast two-
hybrid. Furthermore, expression of GFP-tagged full-length
Sec10 did not inhibit cell spreading (unpublished data).
Based on these observations, we conclude that the activity of
the exocyst is required for ARF6-induced membrane recy-
cling from the RE during cell spreading, and therefore, that
the exocyst serves as a downstream ARF6 effector complex
in post-endocytic recycling.
 
Discussion
 
In this paper, we identify a novel mechanism by which
GTP-bound ARF6 promotes membrane recycling toward
specialized plasma membrane regions: ARF6 recruits the
exocyst complex to sites of plasma membrane growth.
We report that a domain comprising the last 330 residues
of Sec10 interacts with ARF6 by a two-hybrid screen and in
pull-down assays. This association is direct, and occurs prefer-
entially with activated GTP-ARF6 (Fig. 1). The association of
GTP-ARF6 with Sec10 is reminiscent of interactions reported
recently in yeast and mammalian cells between the exocyst
subunits and several members of the Rab, Rho, and Ral small
GTP-binding protein subfamilies (for review see Lipschutz
Figure 6. Selective loss of Sec10 from perinuclear compartments 
by expression of activated ARF6. Subconfluent MDCK cells grown 
on coverslips were transiently transfected with constructs encoding 
HA-tagged dominant inhibitory ARF6-T27N (A and B), or constitutively 
activated ARF6-Q67L (C–H). (A and B) Cells expressing ARF6-T27N 
were double labeled with anti-HA (B, green) and anti-Sec10 (A, red 
in B). ARF6-T27N has no effect on the perinuclear localization of 
Sec10 (arrows). (C and D) Cells expressing ARF6-Q67L were double 
labeled with anti-HA (D, green) and anti-Sec10 (C, red in D). ARF6-
Q67L expression induces a disappearance of Sec10 from perinuclear 
compartments (arrows). (E–H) Cells expressing ARF6-Q67L were 
double labeled with anti-HA (F and H, green) and anti-GM130 
(E, red in F), or with TGN38 (G, red in H). ARF6-Q67L expression 
has no effect on the distribution of Golgi marker GM130 or TGN 
marker TGN38 proteins (arrows). Bars, 10  m. 
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and Mostov, 2002; Novick and Guo, 2002). In yeast, the exo-
cyst complex acts presumably by targeting secretory vesicles to
sites of exocytosis (Finger and Novick, 1998). Recruitment of
Sec15p to secretory vesicles requires its interaction with GTP-
Sec4p, a Rab protein functioning in Golgi to plasma mem-
brane transport in yeast (Finger et al., 1998; Guo et al.,
1999b). At a later stage on the secretory pathway, interaction
of Sec3p with GTP-Cdc42p and GTP-Rho1p, two Rho pro-
teins essential for cell polarity establishment and maintenance,
is probably required to direct exocytosis to the bud (Grote et
al., 2000; Guo et al., 2001; Zhang et al., 2001). In mamma-
lian cells, Sec5 interacts with GTP-Ral (Moskalenko et al.,
2002), which may regulate complex assembly (Moskalenko et
al., 2002), whereas interaction of Exo70 with the Rho protein
TC10 has recently been implicated in trafficking of Glut4 to
the plasma membrane (Inoue et al., 2003). The mammalian
exocyst complex is found at specialized sites of the plasma
membrane along the axon and in the growth cone of neuronal
cells, as well as at epithelial cell–cell contacts (Grindstaff et al.,
1998; Hazuka et al., 1999; Lipschutz et al., 2000). 
Figure 7. Localization of Sec10 in dy-
namic regions of the plasma membrane 
in GTP-ARF6–expressing cells. Inducible 
expression of HA-tagged ARF6-Q67L in 
MDCK cells was established using the 
Tet-Off™ system. MDCK cells (clone 15) 
were cultured in doxycycline-free 
( Dox) medium for 48 h to induce 
ARF6-Q67L expression (Fig. S2, available 
at http://www.jcb.org/cgi/content/full/
jcb.200305029/DC1). Ultrathin cryosec-
tions were labeled with anti-Sec10 pAbs, 
followed by protein A 10-nm gold. In 
MDCK cells expressing ARF6-Q67L, the 
plasma membrane exhibited extensive 
membrane folds and extensions appearing 
as electroluescent structures (asterisks). 
Sec10 is detected along plasma mem-
brane folds (arrows) and in membrane 
invaginations and tubulo-vesicular 
structures in close proximity to the 
ruffled plasma membrane (arrowheads). 
Bar, 200 nm.
Figure 8. Expression of the dominant-
inhibitory Sec10 amino-terminal domain 
inhibits ARF6-Q67L–induced spreading 
of NRK cells. NRK cells grown on glass 
coverslips were transiently transfected 
with GFP (A), HA-tagged ARF6-Q67L 
(B), or HA-tagged ARF6-Q67L and GFP-
tagged Sec10NTer (aa 1–537). (C) Cells 
were fixed and processed for immuno-
fluorescence labeling with anti-HA–tagged 
mAb to detect ARF6-Q67L (B and C). 
A and the inset in C show the fluores-
cence signal of GFP (A) or GFP-tagged 
Sec10NTer (C, inset). Arrows in C 
(and inset) depict cells expressing both 
ARF6-Q67L and Sec10NTer, whereas 
cells labeled with arrowheads showed no 
detectable expression of Sec10NTer and 
expressed only ARF6-Q67L. (D) Box plot 
distribution of projected area of cells 
expressing GFP, ARF6-Q67L, Sec10NTer, 
or ARF6-Q67L together with Sec10NTer. 
Cell pixel area was determined with 
MetaMorph
®. The number of cells in 
each data set is presented below each 
distribution. The top line of each box 
represents the third quartile, the middle 
line the median, and the bottom line the 
first quartile. Circles indicate outliers. 
Statistical analysis (t test) revealed significant difference between GFP and ARF6-Q67L–expressing cell populations (P   0.001), as well as 
between populations of cells expressing ARF6-Q67L alone, or in combination with Sec10NTer (P   0.001). Bars, 10  m. 
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An intracellular pool of the complex is also detected on the
TGN (Vega and Hsu, 2001; Yeaman et al., 2001; Fig. 3, A
and D). Interestingly, expression of dominant-inhibitory
Sec10 and Sec8 blocks neurite outgrowth in PC12 cells and
trafficking to the basolateral membrane in MDCK cells, re-
spectively (Lipschutz et al., 2000; Vega and Hsu, 2001). In
addition, Sec10 overexpression stimulates tubule formation
in an in vitro model of kidney tubulogenesis (Yeaman et al.,
2001). All together, these results support the idea that the
exocyst complex is required for transport between the TGN
and sites of plasma membrane growth. Our data indicate that
the perinuclear distribution of the exocyst complex in mam-
malian cells is not restricted to the TGN (Vega and Hsu,
2001; Yeaman et al., 2001), but extends into REs. Here, we
demonstrate that TfR-containing endocytic buds that are
abundant on REs (Stoorvogel et al., 1996) carry endogenous
Sec10. This is consistent with data showing that Exo70 and
Sec8 exocyst subunits are associated with TfR-positive REs in
MDCK cells (Folsch et al., 2003). However, it is unlikely
that the recruitment of Sec10 to the RE requires GTP-bound
ARF6, as perinuclear Sec10 localization is not affected by
dominant-inhibitory ARF6 that lowers GTP-ARF6 level.
Rather, our observations indicate that GTP-ARF6, which ac-
cumulates at the plasma membrane (D’Souza-Schorey et al.,
1998; Frank et al., 1998; Franco et al., 1999; Vitale et al.,
2002), triggers the localization of Sec10, and the exocyst
complex, to plasma membrane protrusions and invaginations
that form upon ARF6 activation (Fig. 7).
Depending on the cell types, ARF6 has been shown to
control the recycling of proteins endocytosed through the
clathrin-dependent pathway (D’Souza-Schorey et al., 1995,
1998), or to transport proteins that are endocytosed inde-
pendently of clathrin (Radhakrishna and Donaldson, 1997;
Naslavsky et al., 2003). Although it has not been clarified
whether these pathways intersect and whether recycling ma-
terials follow a common route back to the plasma mem-
brane, ARF6 activity has consistently been associated with
the formation of actin-based plasma membrane protrusions
(Song et al., 1998; Franco et al., 1999; Radhakrishna et al.,
1999; Palacios et al., 2001). Accordingly, ARF6 is impli-
cated in the regulation of cellular processes requiring a tran-
sient mechanism to deliver membranes to regions of the cell
surface reorganization. A common feature of these processes
(including membrane ruffling, cell spreading, cell motility,
and phagocytosis; Song et al., 1998; Zhang et al., 1998;
Radhakrishna et al., 1999; Palacios et al., 2001; Santy and
Casanova, 2001; Niedergang et al., 2003) is that polarized
endocytic recycling contributes to cellular polarization. Di-
rectional recycling of TfRs and integrins to the leading edge
has been reported during cell spreading and motility in fi-
broblasts (Hopkins et al., 1994; Pierini et al., 2000; Laukai-
tis et al., 2001; Roberts et al., 2001). Similarly, recycling en-
docytic vesicles positive for VAMP3 insert at the site of
pseudopod extension during phagocytosis in macrophages,
in a process that is under ARF6 control (Bajno et al., 2000;
Niedergang et al., 2003). Here, we found that spreading of
ARF6-Q67L–expressing NRK cells is strongly inhibited by
coexpression of dominant-inhibitory Sec10. This observa-
tion, together with the reported inhibition of NRK and
HeLa cell spreading upon inhibition of ARF6 function
(Radhakrishna and Donaldson, 1997; Song et al., 1998),
suggests that membrane delivery from internal endocytic
reservoirs is a major player during cell spreading in a process
that involves the ARF6/exocyst complex machinery control-
ling membrane insertion at the plasma membrane.
Therefore, we favor a model that considers that local
ARF6 activation at the plasma membrane is required for po-
larized membrane recycling and insertion through interac-
tion of GTP-ARF6 with the vesicle-tethering exocyst com-
plex. According to this model, interfering with exocyst
complex activity is expected to impair docking of recycling
transport intermediates with the plasma membrane. Indeed,
we observed a partial inhibition of Tf recycling in Sec5-
depleted cells, consistent with the observation that only a
fraction of Tf recycles to the plasma membrane through REs
(Sheff et al., 1999). In addition, the observation that domi-
nant inhibition of Sec10 function triggers the formation of
an extensive endocytic tubular network is also consistent
with an essential role of the exocyst complex in endocytic re-
cycling. Analogous to findings in yeast where inhibition of
Sec10p leads to intracellular membrane accumulation (Roth
et al., 1998), we believe that this morphological change is
produced by interfering with the docking of recycling trans-
port intermediates with the plasma membrane. Although our
findings bring novel insights as to how ARF6 may control
delivery of recycling vesicles, they do not explain how the
exocyst complex can operate simultaneously in post-Golgi
and endocytic recycling pathways without mixing. One pos-
sibility is that specificity is provided earlier when the exocyst
complex is recruited to donor compartments or vesicles.
In yeast, Sec4p acts as a bridge between the exocyst and
post-Golgi transport vesicles by interacting with Sec15p
(Finger et al., 1998; Guo et al., 1999b). Interestingly, two
sec15 genes have been identified in mammalian cells en-
coding two related proteins (Sec15A and Sec15B; Kee et
al., 1997; Brymora et al., 2001). These observations sug-
gest the existence of at least two forms of the exocyst com-
plex that may interact with specific Rab GTPases on dis-
tinct membranes. Directionality and specificity may also
be achieved by polarized vesicle transport. Recently, it has
been shown that a subset of microtubules could serve as a
track to facilitate export from the RE to the cell surface
(Lin et al., 2002), and a direct association of the exocyst
complex with microtubules has been reported (Vega and
Hsu, 2001). Future experiments should define the func-
tion of ARF6 in coordinating these various mechanisms
that target post-endocytic recycling to sites of membrane
growth during cell polarization.
 
Materials and methods
 
Cell culture, antibodies, and reagents
 
MDCK I cells and NRK cells were cultured in DME supplemented with
10% FBS, penicillin, and streptomycin. pAbs against Sec10 were gener-
ated against a synthetic peptide (ELFEEPFVADEYIER) corresponding to aa
6–20 of human Sec10. Anti-Sec10 antibodies from rabbit sera were puri-
fied by affinity chromatography on the Sec10 peptide immobilized on a
HiTrap™ NHS-activated HP column (Amersham Biosciences). Rat mAb
against HA tag (clone 3F10) was purchased from Roche. Anti-GM130
(clone 35) and anti–rat Sec8 (clone 14) mouse mAbs were purchased from
BD Biosciences. Anti–human TfR (intracellular domain) mouse mAb
(clone H68.4) was obtained from Zymed Laboratories. Mouse mAb against 
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rat Sec6 (clone 9H5) was purchased from StressGen Biotechnologies. Rab-
bit pAbs against ARF6, and TGN38 were provided by Drs. V.W. Hsu
(Brigham and Women’s Hospital, Boston, MA) and G. Banting (University
of Bristol, UK), respectively. Mouse mAb against Exo70 was a gift of Dr.
S.-C. Hsu (Rutgers University, Piscataway, NJ). Anti-Sec5 antibodies were
generated by immunization of rabbits with the Ral-binding domain of Sec5
fused to GST (Moskalenko et al., 2003). Cy2- and Cy3-conjugated second-
ary antibodies were purchased from Jackson ImmunoResearch Laborato-
ries. Alexa
 
®
 
-conjugated Tf was purchased from Molecular Probes, Inc.
 
Yeast two-hybrid screening
 
Two-hybrid screening was performed using a mating protocol with L40 and
Y187 yeast strains, using a fusion of LexA with ARF6-Q67L as a bait and a
human placenta random-primed cDNA library fused to the Gal4 activation
domain, using standard procedures (Vojtek and Hollenberg, 1995).
 
ARF6–Sec10 binding assays
 
Sequences encoding full-length Sec10 or its amino-terminal region
(Sec10NTer; aa 378–708) were subcloned into pGEX4T1 at the carboxy
terminus of GST and transformed in 
 
E. coli
 
 BL21(DE3) strain. Expression
was induced with 0.5 mM isopropyl 
 
 
 
-
 
D
 
-thiogalactopyranoside for 5 h at
25
 
 
 
C. The fusion protein was purified by affinity chromatography on glu-
tathione-Sepharose beads (Amersham Biosciences). After elution with glu-
tathione, the purified protein was dialyzed against 20 mM Tris, pH 7.4,
100 mM NaCl, 2 mM EDTA, 2 mM 
 
 
 
-mercaptoethanol, and 10% glycerol,
and was stored at 
 
 
 
80
 
 
 
C.
For the in vitro binding assay, recombinant ARF6 (rARF6) was purified
from 
 
E. coli
 
 mostly as a GTP-bound form as described previously (Chavrier
and Franco, 2001). Loading with GDP was obtained by the addition of 2
mM EDTA (free Mg
 
2
 
  
 
 
 
1 
 
 
 
M) in the presence of 5 mM excess GDP for 60
min at 25
 
 
 
C, followed by addition of 2 mM MgCl
 
2
 
. In these conditions,
 
 
 
50% of rARF6 was converted in the GDP-bound form. Separation of the
GTP- and GDP-bound forms of ARF6 (5 mg total rARF6) was performed by
chromatography on a cation exchange column (Mono S HR5/5; Amersham
Biosciences) equilibrated in buffer A (50 mM Tris-HCl, pH 7.5, 1 mM
MgCl
 
2
 
, 1 mM DTT, and 10 
 
 
 
M GDP) at a flow rate of 1 ml/min. Elution
was performed with a linear gradient of 0–1 M NaCl in buffer A, GTP- and
GDP-ARF6 eluting at 
 
 
 
70 mM and 110 mM NaCl, respectively. 8 
 
 
 
M
GTP- or GDP-bound rARF6 was incubated together with GST or GST-
Sec10, and was bound to glutathione-Sepharose beads (4 
 
 
 
M) for 60 min
at 4
 
 
 
C in binding buffer (50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 2 mM
MgCl
 
2
 
, 1 mM DTT, and 0.5% Triton X-100) containing 100 
 
 
 
M GDP
(GDP-ARF6 binding experiment) or GTP (GTP-ARF6 binding experiment)
and 0.5% BSA (wt/vol). Beads were washed twice with binding buffer plus
0.5% BSA and twice with binding buffer. Bound proteins were eluted in
SDS sample buffer and separated by SDS-PAGE. rARF6 in the bound (10%
of total) and unbound (1% of total) fraction was detected by immunoblot-
ting analysis using anti-ARF6 antibodies.
For the in vivo binding assay, HeLa cells were transfected with plasmids
encoding HA-tagged ARF1 and ARF6 variants using the calcium-phos-
phate method. Cells were lysed 36 h after transfection with 50 mM Tris,
pH 7.4, 100 mM NaCl, 1 mM EDTA, 1% Triton X-100, and a cocktail of
protease inhibitors (Roche), and centrifuged at 13,000 rpm for 5 min at
4
 
 
 
C. Supernatants were incubated with GST or GST-Sec10 for 30 min at
4
 
 
 
C in the presence of 0.1% BSA, and then glutathione-Sepharose beads
were added for 1 h further. Beads were washed three times with 1 ml 50
mM Tris, pH 7.4, 100 mM NaCl, 1 mM EDTA, and 1% Triton X-100.
Bound proteins were eluted using SDS sample buffer, and were separated
by SDS-PAGE. The presence of ARF on the beads was detected by Western
blot analysis using anti-HA antibodies.
 
Generation of stable MDCK cell lines
 
cDNAs encoding HA-tagged ARF6-T27N and -Q67L have been described
previously (Franco et al., 1999). Tet-Off™ MDCK cells were transfected
with FuGENE™ 6 reagent with the cDNA-encoding HA-tagged ARF6-
Q67L subcloned in pTRE expression vector (CLONTECH Laboratories,
Inc.) and pSPGK-Hygro. Resistant clones were maintained in medium con-
taining 400 
 
 
 
g/ml hygromycin, 200 
 
 
 
g/ml G418, and 1 
 
 
 
g/ml doxycy-
cline. Regulated expression of HA-tagged ARF6-Q67L in resistant clones
was assessed by immunoblotting analysis with anti-ARF6 antibodies after
72 h of culture with or without doxycycline. Two clones (named clone 15
and 17) were selected, and gave identical results.
 
Transient transfection and Tf uptake
 
Expression plasmid for dominant inhibitory Sec10 (aa 1–537) was gener-
ated by PCR from human Sec10 cDNA (a gift of Dr. P. De Camilli, Yale
University School of Medicine, New Haven, CT) and by in-frame insertion
at the carboxy terminus of E-GFP in the pEGFP-C1 expression vector
(CLONTECH Laboratories, Inc.).
For transient transfection, MDCK I cells were trypsinized and resus-
pended at a density of 2.5 
 
 
 
 10
 
7
 
 cells/ml in culture medium supplemented
with 15 mM Hepes, pH 7.5. 5 
 
 
 
 10
 
6 
 
cells were electroporated in a 0.4-cm
cuvette (Equibio) with 20 
 
 
 
g plasmid DNA encoding HA-tagged ARF6-
Q67L variants (Franco et al., 1999) with a Gene Pulser II apparatus (950 
 
 
 
F,
240 V; Bio-Rad Laboratories). Cells were usually analyzed 36 h after trans-
fection. NRK cells grown on coverslips were transfected with FuGENE™ 6
reagent (Roche) according to the manufacturer’s procedure. For Tf uptake,
30 h after transfection, cells were incubated in internalization medium
(DME supplemented with 20 mM Hepes, pH 7.4, and 1% wt/vol BSA) for 30
min at 37
 
 
 
C. Then, cells were incubated in internalization medium contain-
ing 10 
 
 
 
g/ml Alexa
 
®
 
 546–conjugated human Tf (Molecular Probes, Inc.) for
30 min. Cells were fixed and processed for immunofluorescence labeling.
 
Immunofluorescence microscopy
 
Cells on coverslips were fixed, permeabilized, immunolabeled, and visual-
ized for fluorescence staining as described previously (Guillemot et al.,
1997). Optical sections were taken with a confocal microscope (TCS SP2;
Leica). For determination of projected cell area, images were analyzed
with the Integrated Morphometry Analysis module of MetaMorph
 
®
 
 5.04
software (Universal Imaging Corp.).
 
Quantification of Tf recycling
 
HeLa cells were transfected with siRNA duplex (Dharmacon) specific for
human Sec5 with Oligofectamine
 
®
 
 according to the manufacturer’s in-
struction (Invitrogen; Elbashir et al., 2001; Sec5 siRNA duplex: (Sec5–1),
5
 
 
 
-CGGCAGAAUGGAUGUCUGC-3
 
 
 
; (Sec5–2), 5
 
 
 
-GGUCGGAAAGA-
CAAGGCAGAU-3
 
 
 
). After 72 h, cells were detached in 1% EDTA/PBS and
pelleted. Cells were resuspended in internalization medium (DME, 10 mM
Hepes, pH 7.4, and 0.1% BSA) supplemented with 50 nM Alexa
 
®
 
 488–
labeled human Tf and incubated at 37
 
 
 
C. After 30 min, cells were diluted
with cold internalization medium, pelleted, and resuspended in cold inter-
nalization medium supplemented with 1.5 
 
 
 
M human holo-Tf. An aliquot
of cells was taken and kept on ice (time 0), and the remaining cells were
incubated at 37
 
 
 
C. At the indicated time during the recycling period, ali-
quots of cells were taken, diluted four times in 0.1% BSA/PBS, and kept on
ice. All time points were done in duplicate. FACS
 
®
 
 analysis was performed
using a FACScan™ (Becton Dickinson) measuring Alexa
 
®
 
 488 in FL1. Live
cells were selected using a forward scatter/side scatter gate, and data from
at least 2 
 
 
 
 10
 
3
 
 live cells were acquired. The mean Alexa
 
®
 
 488 fluores-
cence was calculated as the averaged means of duplicate samples.
 
Electron microscopy
 
For immunogold labeling on ultrathin cryosections, cells were fixed with
2% PFA in PBS for 2 h at RT. Fixed cells were processed for ultrathin cryo-
sectioning, and were immunogold labeled (Raposo et al., 1997). Antibod-
ies were visualized with Protein A–gold conjugates (purchased from the
Department of Cell Biology, Utrecht University, Utrecht, Netherlands). Af-
ter staining and embedding with a mixture of uranyl acetate and methyl-
cellulose, sections were viewed at 80 kV with a transmission electron mi-
croscope (Philips CM120; FEI Company).
For whole-mount EM, immunogold labeling of Sec10 and TfR on en-
tire NRK cells was performed as described by Stoorvogel et al. (1996) on
cells grown for 2 d on formvar-coated gold grids. In brief, after washing
with MEM, 20 mM Hepes, pH 7.4, cells were starved for 45 min in the
same medium at 37
 
 
 
C and then incubated for 45 min with 50  g/ml of
HRP-conjugated mouse Tf (Pierce Chemical Co.). Cells were rapidly
cooled at 4 C and incubated in DAB-H2O2–containing buffer in order to
fill Tf-containing compartments with DAB polymer that served as an
electron-dense marker for endosomes. Soluble cytosolic proteins were
removed by permeabilization with saponin, and cells were then fixed
with 3% PFA in 0.1 M phosphate buffer, pH 7.4, for 2 h. Immunogold la-
beling was performed at RT in the presence of saponin and using cold
fish gelatin as blocking buffer. After labeling, cells on grids were fixed
with 2% glutaraldehyde, rinsed in water, dehydrated in increasing con-
centrations of ethanol, and critical point dried in a critical point dry ap-
paratus (Balzers). Samples were viewed with a transmission electron mi-
croscope (Philips CM120; FEI Company).
Subcellular fractionation, immunoprecipitation, and 
immunoblotting analysis
For subcellular fractionation, MDCK Tet-Off™ cells from two selected
clones stably transfected with HA-tagged ARF6-Q67L (clones 15 and 17)1120 The Journal of Cell Biology | Volume 163, Number 5, 2003
were cultured in the presence of 1  g/ml doxycycline ( Dox), or switched
to doxycycline-free ( Dox) medium for 72 h. Cells from the different pop-
ulations (4   10
6 cells from two 10-cm-diam dishes) were washed and
scraped in PBS and homogenized in 250 mM sucrose, 3 mM imidazole,
pH 7.4, with protease inhibitors by repeated passages through a 25G
5/8
needle. Homogenate was subjected to a 1,000-g spin to yield a postnu-
clear supernatant (PNS). PNS was subjected to a 100,000-g spin to yield
soluble (S) and pellet (P) fractions. Pellets were resuspended in sample
buffer to volumes equal to that of the corresponding supernatants, and
equal volumes of P and S fractions were loaded per lane (corresponding to
25  g total protein from the soluble fraction). For immunoprecipitation
analysis, 2   10
6 MDCK cells were lysed in 1% Triton X-100, 150 mM
NaCl, 2 mM EDTA, and 30 mM Tris, pH 7.6, with protease inhibitors at
4 C. Lysates were cleared by centrifugation at 13,000 g for 10 min at 4 C,
and 5  g affinity-purified rabbit anti-Sec10 antibodies or 2.5  g mAb
against Sec8 were added for 30 min at 4 C. Then, protein G–Sepharose
beads (Amersham Biosciences) were added, incubated for 5 h at 4 C, and
washed three times in lysis buffer and once in 50 mM Tris, pH 7.5. Pro-
teins were separated on 8% polyacrylamide gels and transferred to PVDF
membranes. Detection of bound antibodies was performed with the ECL
procedure (Amersham Biosciences).
Online supplemental material
Fig. S1 shows the characterization of anti-Sec10 pAbs. Fig. S2 shows the
characterization of MDCK Tet-Off™ cells (clone 15) stably transformed
with HA-tagged ARF6-Q67L. The online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200305029/DC1.
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